Infant Formula E. Sakazakii Requirement In Final Rule Unnecessary, IFC Says
This article was originally published in The Tan Sheet
FDA should not create a microbiological testing requirement for E. sakazakii in infant formula, the International Formula Council states in Aug. 26 comments on the agency's proposed infant formula GMPs and quality control procedures
You may also be interested in...
Industry and FDA should collaborate on a rigorous microbiological sampling program to test powdered infant formula for possible contaminants such as Enterobacter sakazakii bacteria, according to the agency's Food Advisory/Contaminants and Natural Toxicants Subcommittee
Increased educational efforts to help avoid the risk of serious health problems resulting from Enterobacter sakazakii bacterial contamination of powdered infant formula were recommended by an FDA advisory group at a March 19 meeting in Riverdale, Md
The U.S. is requesting that the Codex Committee on Nutrition & Foods for Special Dietary Uses (CCNFSDU) address concerns related to the presence of pathogens in infant formula